Raising Funds for M&A and Growth Investments through the 9th and 10th Stock Acquisition Rights
First written in FY2021. 9 of 13 entries say "Advanced", first in FY2022-Q1. Latest entry: FY2027-H1.
3 other companies' latest entry also says "Other".
- FY2027-H1No disclosure related to stock acquisition rightsAnnual report
「There are no applicable matters.」
The Company states that there were no applicable matters during the interim period regarding the exercise of stock options, other share acquisition rights, or bonds with share acquisition rights incorporating provisions for adjustment of the exercise price, among others. - 2026-03-12AdvancedEarnings
「While proceeds from the issuance of shares amounted to ¥519,355 thousand」
The issuance of shares through the exercise of share acquisition rights and related fundraising progressed during the period. - FY2026-H1AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights. In addition, between 1 August 2025 and 31 August 2025, the exercise of stock acquisition rights increased the total number of issued shares by 6,300, capital stock by ¥3.357 million and capital reserves by ¥3.357 million.」
During the interim consolidated accounting period, the total number of shares issued increased by 437,100 through the exercise of stock acquisition rights, while capital and the capital surplus each increased by ¥226.097 million. A further 6,300 shares were exercised before the filing date. - FY2025Continuation of remaining financing capacityAnnual report
「Tenth Series Stock Acquisition Rights with an exercise price adjustment provision (issued 5 February 2021) Common shares 510,000」
No Tenth Series Stock Acquisition Rights were exercised during the fiscal year. The remaining capacity of 510,000 shares and the exercise period through 6 February 2026 continue to be disclosed. - FY2024Update on remaining financing capacityAnnual report
「Tenth Series Stock Acquisition Rights with an exercise price adjustment provision (issued 5 February 2021) Common shares 510,000 (Note) 3」
No Tenth Series Stock Acquisition Rights were exercised during the fiscal year, and 510,000 shares underlying the Tenth Series Stock Acquisition Rights remain available for raising growth investment funds. - FY2023AdvancedAnnual report
「Cumulative number of shares delivered in connection with bonds with stock acquisition rights with exercise price adjustment provisions, etc. as of the end of the period (shares) 634,600 Cumulative funds raised in connection with bonds with stock acquisition rights with exercise price adjustment provisions, etc. as of the end of the period (¥ million) 838」
Regarding the raising of growth investment funds through the Ninth and Tenth Series Stock Acquisition Rights, cumulative funds raised reached ¥838 million and cumulative shares delivered reached 634,600. - FY2023-Q2AdvancedAnnual report
「Number of bonds with stock acquisition rights with exercise price adjustment provisions, etc. exercised during the quarter (rights) 1,612 Number of shares delivered upon exercise during the quarter (shares) 161,200 Funds raised through exercises during the quarter (¥ million) 194 Cumulative number of bonds with stock acquisition rights with exercise price adjustment provisions, etc. exercised as of the end of the quarter (rights) 2,398 Cumulative number of shares delivered upon exercise of bonds with stock acquisition rights with exercise price adjustment provisions, etc. as of the end of the quarter (shares) 239,800 Cumulative funds raised through exercises of bonds with stock acquisition rights with exercise price adjustment provisions, etc. as of the end of the quarter (¥ million) 289」
Regarding the Ninth and Tenth Series Stock Acquisition Rights, ¥194 million was raised during the quarter, bringing cumulative funds raised to ¥289 million and cumulative shares delivered to 239,800. Financing for M&A, system investments, 3D and robotics development, and expansion of prime-contractor orders is progressing. - FY2023-Q1AdvancedAnnual report
「Number of adjustment-price stock acquisition rights with bonds exercised during the quarter (units) 786 Number of shares delivered upon exercise during the quarter (shares) 78,600 Funds raised through exercise during the quarter (¥ million) 94」
Regarding the Ninth and Tenth Series Stock Acquisition Rights, ¥94 million was raised during the quarter and 78,600 shares were delivered. Financing for M&A, system investments, 3D and robotics development, and expansion of prime-contractor orders is progressing. - FY2022AdvancedAnnual report
「Partial exercise of the Ninth Series Stock Acquisition Rights issued in February 2021 raised ¥549 million. Capital increased by ¥279 million to ¥696 million as of 31 January 2022.」
Regarding the raising of growth investment funds through the Ninth and Tenth Series Stock Acquisition Rights, ¥549 million was raised during the consolidated fiscal year, and capital increased to ¥696 million. The funds are planned to be used for M&A, system investments, 3D and robotics development, and expansion of prime-contractor orders. - FY2022-Q3AdvancedAnnual report
「Number of bonds with stock acquisition rights with exercise price adjustment provisions, etc. exercised during the quarter (rights) 2,337 Number of shares delivered upon exercise during the quarter (shares) 233,700 Funds raised through exercises during the quarter (¥ million) 317 Cumulative number of bonds with stock acquisition rights with exercise price adjustment provisions, etc. exercised as of the end of the quarter (rights) 3,628 Cumulative number of shares delivered upon exercise of bonds with stock acquisition rights with exercise price adjustment provisions, etc. as of the end of the quarter (shares) 362,800 Cumulative funds raised through exercises of bonds with stock acquisition rights with exercise price adjustment provisions, etc. as of the end of the quarter (¥ million) 510」
Regarding the Ninth and Tenth Series Stock Acquisition Rights, ¥317 million was raised during the quarter, bringing cumulative funds raised to ¥510 million and cumulative shares delivered to 362,800. - FY2022-Q2AdvancedAnnual report
「Number of bonds with stock acquisition rights with exercise price adjustment provisions, etc. exercised during the quarter (rights) 1,055 Number of shares delivered upon exercise during the quarter (shares) 105,500 Funds raised through exercises during the quarter (¥ million) 155 Cumulative number of bonds with stock acquisition rights with exercise price adjustment provisions, etc. exercised as of the end of the quarter (rights) 1,291 Cumulative number of shares delivered upon exercise of bonds with stock acquisition rights with exercise price adjustment provisions, etc. as of the end of the quarter (shares) 129,100 Cumulative funds raised through exercises of bonds with stock acquisition rights with exercise price adjustment provisions, etc. as of the end of the quarter (¥ million) 193」
Regarding the Ninth and Tenth Series Stock Acquisition Rights, ¥155 million was raised during the quarter, bringing cumulative funds raised to ¥193 million and cumulative shares delivered to 129,100. - FY2022-Q1AdvancedAnnual report
「Ninth Series Stock Acquisition Rights with an exercise price adjustment provision (issued 5 February 2021) Common shares 850,000 (Note) 3 Tenth Series Stock Acquisition Rights with an exercise price adjustment provision (issued 5 February 2021) Common shares 510,000 (Note) 3」
The issuance details of the Ninth and Tenth Series Stock Acquisition Rights were reflected in the quarterly report, specifying a financing instrument covering a total of 1,360,000 shares. In addition, 236 rights were exercised during the quarter, raising ¥38 million. - FY2021First statedAnnual report
「The funds raised through this financing are planned to be used for future M&A investments that will contribute to enhancing corporate value. In parallel with pursuing these M&A investments, the funds are also planned to be used for system investments aimed at further business growth, development of demolition technologies for “3D Demolition” using cutting-edge 3D technology, robot development to pursue the business value of the 3D business, and marketing expenses to increase direct orders as the prime contractor.」
The company issued the Ninth and Tenth Series Stock Acquisition Rights through a third-party allotment to institutional investors, specifying for the first time a financing measure that would allocate estimated net proceeds of ¥2,589.488 million to M&A, system investments, 3D and robotics development, and expansion of prime-contractor orders.